3,4-dihydroxyphenylacetic acid has been researched along with naltrexone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 14 (87.50) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LaVigne, SD; Lookingland, KJ; Manzanares, J; Moore, KE | 1 |
| Lookingland, KJ; Moore, KE | 1 |
| Devine, DP; Leone, P; Pocock, D; Wise, RA | 1 |
| Benjamin, D; Grant, ER; Pohorecky, LA | 1 |
| Funada, M; Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H; Saitoh, A; Suzuki, T | 1 |
| Funada, M; Misawa, M; Nagase, H; Narita, M; Suzuki, T | 2 |
| Lookingland, KJ; Manzanares, J; Moore, KE; Wagner, EJ | 1 |
| Durham, RA; Lookingland, KJ; Manzanares, J; Moore, KE | 1 |
| Bardo, MT; Kolta, MG | 1 |
| Colado, MI; de Cabo, C; Martín, MI; Viveros, MP | 1 |
| Ahtee, L; Piepponen, TP | 1 |
| Durham, RA; Johnson, JD; Lookingland, KJ; Moore, KE | 1 |
| Javelle, N; Lambás-Señas, L; Renaud, B | 1 |
| Berger, SP; Broderick, PA; Hsu, K; Reid, MS; Souza, KH | 1 |
| Chudapongse, N; Ho, IK; Kim, SY; Kramer, RE; Sasaki, K | 1 |
16 other study(ies) available for 3,4-dihydroxyphenylacetic acid and naltrexone
| Article | Year |
|---|---|
Activation of tuberohypophysial dopamine neurons following intracerebroventricular administration of the selective kappa opioid receptor antagonist NOR-binaltorphimine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hydrazines; Injections, Intraperitoneal; Male; Naltrexone; Narcotic Antagonists; Neurons; Nucleus Accumbens; Pituitary Gland; Pituitary Gland, Posterior; Rats; Receptors, Opioid, kappa | 1991 |
Acute effects of morphine on neurochemical estimates of activity of incertohypothalamic dopaminergic neurons in the male rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry; Hypothalamus; Male; Methyltyrosines; Morphine; Naltrexone; Neural Pathways; Neurons; Rats; Rats, Inbred Strains; Time Factors | 1985 |
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Amino Acid Sequence; Analgesics; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Homovanillic Acid; Hydroxyindoleacetic Acid; Limbic System; Male; Microinjections; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Tegmentum Mesencephali | 1993 |
Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Ethanol; Hydroxyindoleacetic Acid; Male; Movement; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Serotonin | 1993 |
Effects of diabetes on spontaneous locomotor activity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Benzylidene Compounds; Brain; Corpus Striatum; Diabetes Mellitus, Experimental; Dopamine; Haloperidol; Homovanillic Acid; Male; Mice; Mice, Inbred ICR; Motor Activity; Naltrexone; Narcotic Antagonists; Prosencephalon; Receptors, Dopamine D1; Receptors, Opioid, delta; Reference Values | 1994 |
Involvement of delta-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Dopamine; Homovanillic Acid; Limbic System; Male; Mice; Mice, Inbred Strains; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Postural Balance; Reaction Time; Receptors, Opioid, delta | 1993 |
Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Apomorphine; Conditioning, Operant; Dopamine; Dynorphins; Homovanillic Acid; Injections, Subcutaneous; Limbic System; Male; Mice; Mice, Inbred Strains; Morphine; Motivation; Naltrexone; Peptide Fragments; Prosencephalon; Pyrrolidines; Receptors, Opioid, kappa; Reward | 1993 |
Neurochemical evidence that estrogen-induced suppression of kappa-opioid-receptor-mediated regulation of tuberoinfundibular dopaminergic neurons is prolactin-independent.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain Chemistry; Dopamine; Dynorphins; Estrogens; Female; Hydrazines; Hypothalamic Hormones; Injections, Intraventricular; Median Eminence; Naltrexone; Nerve Endings; Neurons; Ovariectomy; Peptide Fragments; Prolactin; Rats; Receptors, Opioid, kappa | 1994 |
delta-Opioid receptor-mediated regulation of central dopaminergic neurons in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Injections, Intraventricular; Male; Naltrexone; Narcotic Antagonists; Neurons; Rats; Receptors, Opioid, delta | 1993 |
Opioid modulation of amphetamine-stimulated dopamine release and concentration in rat striatal slices.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Dihydroxyphenylalanine; Dopamine; Hydrazines; In Vitro Techniques; Male; Morphine; Naltrexone; Narcotics; Neostriatum; Rats; Rats, Sprague-Dawley | 1993 |
Naltrexone administration during the preweanling period affects striatal and hypothalamic serotonergic systems, but not midbrain serotonergic or striatal dopaminergic systems in the adult rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Female; Hydroxyindoleacetic Acid; Hypothalamus; Male; Mesencephalon; Naltrexone; Rats; Rats, Wistar; Serotonin; Weaning | 1995 |
Effects of selective opioid receptor antagonists on morphine-induced changes in striatal and limbic dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Limbic System; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Pain Threshold; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu | 1995 |
Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Afferent Pathways; Analgesics; Animals; Cerebral Ventricles; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dopamine Agonists; Dynorphins; Hypothalamus; Hypothalamus, Middle; Injections, Intraperitoneal; Injections, Intraventricular; Limbic System; Male; Median Eminence; Naltrexone; Narcotic Antagonists; Neurons; Nucleus Accumbens; Prolactin; Pyrrolidines; Quinolines; Rats; Receptors, Dopamine D2; Receptors, Opioid, kappa | 1996 |
Monoamine metabolism in the locus coeruleus measured concurrently with behavior during opiate withdrawal: an in vivo microdialysis study in freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Animals; Behavior, Animal; Biogenic Monoamines; Hydroxyindoleacetic Acid; Locus Coeruleus; Male; Microdialysis; Monoamine Oxidase Inhibitors; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Pargyline; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1997 |
Neuropharmacological characterization of local ibogaine effects on dopamine release.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ibogaine; Male; Microdialysis; Naloxone; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 1996 |
Nonopioid receptor-mediated effects of U-50,488H on [Ca(2+)]i and extracellular dopamine in PC12 cells.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Calcium; Dopamine; Dose-Response Relationship, Drug; Intracellular Fluid; Naltrexone; Narcotic Antagonists; PC12 Cells; Rats; Receptors, Opioid, kappa | 2003 |